Literature DB >> 17610590

A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.

Hector Vargas-Perez1, Ryan A Ting-A-Kee, Andrew Heinmiller, Jessica E Sturgess, Derek van der Kooy.   

Abstract

The opponent-process theory of motivation postulates that motivational stimuli activate a rewarding process that is followed by an opposed aversive process in a homeostatic control mechanism. Thus, an acute injection of morphine in nondependent animals should evoke an acute rewarding response, followed by a later aversive response. Indeed, the tegmental pedunculopontine nucleus (TPP) mediates the rewarding effects of opiates in previously morphine-naive animals, but not other unconditioned effects of opiates, or learning ability. The aversive opponent process for acute morphine reward was revealed using a place-conditioning paradigm. The conditioned place aversion induced by 16-h spontaneous morphine withdrawal from an acute morphine injection in nondependent rats was abolished by TPP lesions performed prior to drug experience. However, TPP-lesioned rats did show conditioned aversions for an environment paired with the acute administration of the opioid antagonist naloxone, which blocks endogenous opioids. The results show that blocking the rewarding effects of morphine with TPP lesions also blocked the opponent aversive effects of acute morphine withdrawal in nondependent animals. Thus, this spontaneous withdrawal aversion (the opponent process) is induced by the acute rewarding effects of morphine and not by other unconditioned effects of morphine, the pharmacological effects of morphine or endogenous opioids being displaced from opiate receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610590     DOI: 10.1111/j.1460-9568.2007.05599.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

Review 1.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

2.  An anatomical basis for opponent process mechanisms of opiate withdrawal.

Authors:  Anna K Radke; Patrick E Rothwell; Jonathan C Gewirtz
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

3.  Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 Tesla.

Authors:  Sarah L Withey; Lei Cao; Fernando B de Moura; Kenroy R Cayetano; Michael L Rohan; Jack Bergman; Stephen J Kohut
Journal:  Brain Imaging Behav       Date:  2022-02-28       Impact factor: 3.224

4.  Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats.

Authors:  Hector Vargas-Perez; Ryan Ting-A Kee; Christine H Walton; D Micah Hansen; Rozita Razavi; Laura Clarke; Mary Rose Bufalino; David W Allison; Scott C Steffensen; Derek van der Kooy
Journal:  Science       Date:  2009-05-28       Impact factor: 47.728

5.  BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions.

Authors:  Hector Vargas-Perez; Amine Bahi; Mary Rose Bufalino; Ryan Ting-A-Kee; Geith Maal-Bared; Jenny Lam; Ahmed Fahmy; Laura Clarke; Jennifer K Blanchard; Brett R Larsen; Scott Steffensen; Jean-Luc Dreyer; Derek van der Kooy
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

6.  A thalamic input to the nucleus accumbens mediates opiate dependence.

Authors:  Yingjie Zhu; Carl F R Wienecke; Gregory Nachtrab; Xiaoke Chen
Journal:  Nature       Date:  2016-02-03       Impact factor: 49.962

Review 7.  Glutamate mechanisms underlying opiate memories.

Authors:  Jamie Peters; Taco J De Vries
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

Review 8.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

Review 9.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

10.  Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.